Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5175748
Max Phase: Preclinical
Molecular Formula: C56H77N13O15S
Molecular Weight: 1204.37
Associated Items:
ID: ALA5175748
Max Phase: Preclinical
Molecular Formula: C56H77N13O15S
Molecular Weight: 1204.37
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC1=O
Standard InChI: InChI=1S/C56H77N13O15S/c1-5-30(4)47-55(84)64-37(7-6-20-60-56(58)59)50(79)65-38(21-29(2)3)51(80)67-41(24-33-12-18-36(72)19-13-33)52(81)68-42(25-46(75)76)53(82)66-39(22-31-8-14-34(70)15-9-31)49(78)61-26-44(73)63-43(48(57)77)27-85-28-45(74)62-40(54(83)69-47)23-32-10-16-35(71)17-11-32/h8-19,29-30,37-43,47,70-72H,5-7,20-28H2,1-4H3,(H2,57,77)(H,61,78)(H,62,74)(H,63,73)(H,64,84)(H,65,79)(H,66,82)(H,67,80)(H,68,81)(H,69,83)(H,75,76)(H4,58,59,60)/t30-,37-,38-,39-,40-,41-,42-,43-,47-/m0/s1
Standard InChI Key: BXSSTCWKLUTVAH-RIXNVFHZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1204.37 | Molecular Weight (Monoisotopic): 1203.5383 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Fleming MC, Chiou LF, Tumbale PP, Droby GN, Lim J, Norris-Drouin JL, Williams JG, Pearce KH, Williams RS, Vaziri C, Bowers AA.. (2022) Discovery and Structural Basis of the Selectivity of Potent Cyclic Peptide Inhibitors of MAGE-A4., 65 (10.0): [PMID:35522528] [10.1021/acs.jmedchem.2c00185] |
Source(1):